All Patent Cliff articles
-
BusinessPfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
BusinessIrish pharma exports tumble
Seven of the top 10 drugs going off patent between 2011 and 2014 are produced in Ireland
-
Business
Drug spending to hit $1.2tn in 2016
Growth is expected to bottom out at 3–4% for 2012 and then rise to 5–7% for 2016